Fundraising FoxChimeron Bio
Philadelphia, US · Founded 2015 · Delaware corporation
Find your way into Chimeron Bio
Sign up to see every warm intro you have to Chimeron Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chimeron Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KH
Kevin HeyeckCEO and DirectorHe has experience in venture capital and corporate development in the biotech sector, with expertise in deal structuring, partnerships, and strategic business development.
CD
Chiraag Dilip PatelNamed on SEC filing
TC
Thimmaiah ChendrimadaNamed on SEC filing
JM
Jolly MazmudarNamed on SEC filing
HP
Hemanshu PandyaNamed on SEC filing
Board
Reported raises · per SEC filings
Form D private placements$15.1M disclosed across 4 rounds · 2020–2024
▶$12.8MraisedMar 2025 · 9 investors · BiotechnologyRule 506(b)
▶$12.8MraisedMar 2025 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antonin de FougerollesDirector
- Monica ColemanExecutive Officer
- Kevin HeyeckExecutive Officer, Director
- Afshin SafaviDirector
- Amount sold
- $12.8M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedNov 2022 · 3 investors · BiotechnologyRule 506(b)
▶$1.2MraisedNov 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin HeyeckExecutive Officer, Director
- Afshin SafaviDirector
- Gorka FiusDirector
- Thimmaiah ChendrimadaExecutive Officer
- Antonin de FougerollesDirector
- Offering amount
- $10M
- Amount sold
- $1.2M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$782KraisedMar 2022 · 1 investors · BiotechnologyRule 506(b)
▶$782KraisedMar 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hemanshu PandyaDirector
- Chiraag PatelDirector
- Thimmaiah ChendrimadaExecutive Officer, Director
- Afshin SafaviDirector
- Jolly MazmudarExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $782K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedDec 2020 · 2 investors · Other Health CareRule 506(b)
▶$300KraisedDec 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Monica ColemanExecutive Officer
- Afshin SafaviDirector
- Chiraag Dilip PatelDirector
- Thimmaiah ChendrimadaExecutive Officer, Director, Promoter
- Jolly MazmudarExecutive Officer, Director, Promoter
- Hemanshu PandyaDirector
- Offering amount
- $5M
- Amount sold
- $300K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Chimeron Bio raised?
- Chimeron Bio has disclosed $15.1M raised across 4 rounds.
- Where is Chimeron Bio headquartered?
- Chimeron Bio is headquartered in Philadelphia, US.